Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | PDCD1 | Q15116 | 17/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 17/20 | 0.44 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22966493 | 0.75 | CD274 (0.62) | PDCD1CD274 | |
| SCHEMBL22966620 | 0.74 | PDCD1 (0.65) | PDCD1CD274 | |
| SCHEMBL21452299 | 0.70 | GNRHR (0.40) | SMN1; SMN2 | |
| SCHEMBL5434462 | 0.68 | SMN1; SMN2 (0.49) | SMN1; SMN2SLC6A1CYP1A2 | |
| SCHEMBL2158601 | 0.68 | SMN1; SMN2 (0.49) | SMN1; SMN2SLC6A1CYP1A2 | |
| SCHEMBL315372 | 0.68 | SMN1; SMN2 (0.49) | SMN1; SMN2SLC6A1CYP1A2 | |
| SCHEMBL18291641 | 0.68 | CD274 (0.57) | SMN1; SMN2PDCD1CD274 | |
| SCHEMBL3713831 | 0.67 | SMN1; SMN2 (0.63) | SMN1; SMN2PDCD1CD274CYP1A2 | |
| SCHEMBL3713829 | 0.67 | SMN1; SMN2 (0.63) | SMN1; SMN2PDCD1CD274CYP1A2 | |
| SCHEMBL16714062 | 0.67 | SMN1; SMN2 (0.63) | SMN1; SMN2PDCD1CD274CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019192506-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2019-10-10 | — | — | WO | disclosed |